Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Srivichaivejvivat PCLBKK:VIH-R -1.67%81 EV-to-Revenue is 1.33 as of Aug. 25, 2026, which is 13% below its 10-year median of 1.53. GuruFocus rates BKK:VIH-R with a GF Score™ of 81/100 and a GF Value™ of ฿8.72. The stock has 4 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Srivichaivejvivat PCL ranks better than 59.79% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Srivichaivejvivat PCL's enterprise value is ฿4,170 Mil.
Srivichaivejvivat PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ฿3,128 Mil. Therefore, Srivichaivejvivat PCL's EV-to-Revenue for today is 1.33.
The historical rank and industry rank for Srivichaivejvivat PCL's EV-to-Revenue or its related term are showing as below:
BKK:VIH-R'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.79 Med: 1.53 Max: 4.49
Current: 1.33
During the past 13 years, the highest EV-to-Revenue of Srivichaivejvivat PCL was 4.49. The lowest was 0.79. And the median was 1.53.
BKK:VIH-R's EV-to-Revenue is ranked better than 59.79% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 1.82
vs BKK:VIH-R: 1.33
Srivichaivejvivat PCL's share price for today is ฿8.80.
Srivichaivejvivat PCL's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿5.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Srivichaivejvivat PCL EV-to-Revenue Related Terms
Srivichaivejvivat PCL EV-to-Revenue Historical Data
* Premium members only.
The historical data trend for Srivichaivejvivat PCL's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:VIH-R vs HCA, THC, DVA: EV-to-Revenue Comparison
For the Medical Care Facilities subindustry, Srivichaivejvivat PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Srivichaivejvivat PCL EV-to-Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Srivichaivejvivat PCL's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Srivichaivejvivat PCL's EV-to-Revenue falls into.
Srivichaivejvivat PCL's current Enterprise Value is ฿4,170 Mil.
Srivichaivejvivat PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿3,128 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Srivichaivejvivat PCL (BKK:VIH-R) has a EV-to-Revenue of 1.33 as of Aug. 25, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Srivichaivejvivat PCL and its competitors. This is 13% below median its historical median of 1.53. Over the past decade, Srivichaivejvivat PCL's EV-to-Revenue has ranged from 0.79 to 4.49. According to the industry distribution chart, Srivichaivejvivat PCL ranks #269 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 40.2%.
Is Srivichaivejvivat PCL's EV-to-Revenue too high?
Srivichaivejvivat PCL's current EV-to-Revenue of 1.33 is 13% below median its 10-year median of 1.53. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 4.49. The Healthcare Providers & Services industry median EV-to-Revenue is 1.82. Srivichaivejvivat PCL's value of 1.33 is 26.9% below this industry median. Based on the distribution chart, Srivichaivejvivat PCL ranks #269 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Srivichaivejvivat PCL has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Srivichaivejvivat PCL's EV-to-Revenue compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Srivichaivejvivat PCL ranks #269 out of 669 companies for EV-to-Revenue. This puts Srivichaivejvivat PCL in the upper half of its industry. The industry median EV-to-Revenue is 1.82. Srivichaivejvivat PCL's value of 1.33 is 26.9% below this benchmark. Historically, Srivichaivejvivat PCL's own EV-to-Revenue has ranged from 0.79 to 4.49 over the past decade. While the company's 10-year median is 1.53 vs. the industry median of 1.82, Srivichaivejvivat PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for a Healthcare Providers & Services company?
The median EV-to-Revenue among Healthcare Providers & Services companies is 1.82, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Srivichaivejvivat PCL's current EV-to-Revenue of 1.33 is 26.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Srivichaivejvivat PCL and its competitors. For the Healthcare Providers & Services industry, the median EV-to-Revenue is 1.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Srivichaivejvivat PCL's current EV-to-Revenue is 1.33, which is 13% below median its own 10-year median of 1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Srivichaivejvivat PCL stock overvalued right now?
Srivichaivejvivat PCL (BKK:VIH-R) has a current EV-to-Revenue of 1.33. The stock's GF Value™ is ฿8.72, compared to a current price of ฿8.80 — trading 0.9% above its estimated fair value. The current EV-to-Revenue is 1.33, which is 13% below median its 10-year median of 1.53 and 26.9% below the Healthcare Providers & Services industry median of 1.82. Srivichaivejvivat PCL's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For Srivichaivejvivat PCL (BKK:VIH-R), the current EV-to-Revenue is 1.33 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Srivichaivejvivat PCL (BKK:VIH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Srivichaivejvivat PCL stock appears to be overvalued.
The current stock price of ฿8.80 is trading 0.9% above its estimated GF Value™ of ฿8.72.
Key valuation signals for BKK:VIH-R:
EV-to-Revenue: 1.33 (13% below median its 10-year median of 1.53)
GF Value™: ฿8.72 vs. price of ฿8.80 (0.9% above fair value)
Industry Position: 26.9% below the Healthcare Providers & Services median (#269 of 669)
No single metric tells the full story. See the BKK:VIH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Srivichaivejvivat PCL is engaged in hospital business. The company provides 24-hour medical treatment by specialized doctors, with services in the outpatient department (OPD) by specialized doctors until midnight. Specialized clinics are available, such as comprehensive laparoscopic surgery, orthopedic surgery, urology, vascular surgery, cardiology, nephrology and hemodialysis center, endocrinology, neurology, gastroenterology, pediatric clinic, obstetrics and gynecology clinic, emergency accident center, dental center, health check-up center, Thai Filos Anti-Aging Center. It operates in single segment of hospital business in Thailand only.
81GF Score
Get the complete analysis for BKK:VIH-R
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIH-R has been successfully added to your 
